Annual long term liabilities:
$2.08M-$1.01M(-32.60%)Summary
- As of today (September 14, 2025), MLTX annual total long term liabilities is $2.08 million, with the most recent change of -$1.01 million (-32.60%) on December 31, 2024.
- During the last 3 years, MLTX annual long term liabilities has risen by +$1.84 million (+766.32%).
- MLTX annual long term liabilities is now -48.37% below its all-time high of $4.03 million, reached on December 1, 2020.
Performance
MLTX Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$74.79M+$91.00K(+0.12%)Summary
- As of today (September 14, 2025), MLTX quarterly total long term liabilities is $74.79 million, with the most recent change of +$91.00 thousand (+0.12%) on June 30, 2025.
- Over the past year, MLTX quarterly long term liabilities has increased by +$72.23 million (+2816.74%).
- MLTX quarterly long term liabilities is now at all-time high.
Performance
MLTX quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
MLTX Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.6% | +2816.7% |
| 3 y3 years | +766.3% | +10000.0% |
| 5 y5 years | -48.4% | +100.0% |
MLTX Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.6% | +766.3% | at high | >+9999.0% |
| 5 y | 5-year | -48.4% | +766.3% | at high | >+9999.0% |
| alltime | all time | -48.4% | +766.3% | at high | >+9999.0% |
MLTX Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $74.79M(+0.1%) |
| Mar 2025 | - | $74.70M(+3494.3%) |
| Dec 2024 | $2.08M(-32.6%) | $2.08M(-21.0%) |
| Sep 2024 | - | $2.63M(+2.6%) |
| Jun 2024 | - | $2.56M(-9.1%) |
| Mar 2024 | - | $2.82M(-8.5%) |
| Dec 2023 | $3.08M(+649.9%) | $3.08M(+1048.4%) |
| Sep 2023 | - | $268.50K(-28.7%) |
| Jun 2023 | - | $376.60K(-7.1%) |
| Mar 2023 | - | $405.30K(-1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $411.20K(+71.4%) | $411.20K(+8124.0%) |
| Sep 2022 | - | $5000.00(-73.1%) |
| Jun 2022 | - | $18.60K(-99.5%) |
| Mar 2022 | - | $4.03M(+1577.8%) |
| Dec 2021 | $239.90K(-94.0%) | $239.90K(-94.0%) |
| Sep 2021 | - | $4.03M(0.0%) |
| Jun 2021 | - | $4.03M(0.0%) |
| Mar 2021 | - | $4.03M(0.0%) |
| Dec 2020 | $4.03M | $4.03M(>+9900.0%) |
| Sep 2020 | - | $0.00 |
FAQ
- What is MoonLake Immunotherapeutics annual total long term liabilities?
- What is the all time high annual long term liabilities for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual long term liabilities year-on-year change?
- What is MoonLake Immunotherapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly long term liabilities year-on-year change?
What is MoonLake Immunotherapeutics annual total long term liabilities?
The current annual long term liabilities of MLTX is $2.08M
What is the all time high annual long term liabilities for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual total long term liabilities is $4.03M
What is MoonLake Immunotherapeutics annual long term liabilities year-on-year change?
Over the past year, MLTX annual total long term liabilities has changed by -$1.01M (-32.60%)
What is MoonLake Immunotherapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of MLTX is $74.79M
What is the all time high quarterly long term liabilities for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly total long term liabilities is $74.79M
What is MoonLake Immunotherapeutics quarterly long term liabilities year-on-year change?
Over the past year, MLTX quarterly total long term liabilities has changed by +$72.23M (+2816.74%)